BRCA1-IN-2;Glycinamide, N-[3-(1H-indol-3-yl)-1-oxopropyl]-O-phosphono-L-seryl-N-(4-phenylbutyl)-;BRCA1 IN 2,BRCA1IN2,BRCA-1-IN-2;N-(4-Phenylbutyl)-2-[[(2S)-2-[[3-(1H-indole-3-yl)propanoyl]amino]-3-(phosphonooxy)propanoyl]amino]acetamide
BRCA1-IN-2 is a cell-permeable inhibitor of BRCA1 protein-protein interactions (PPI) with anti-tumor activity by blocking the BRCA1 (BRCT)2/protein interaction.